Singapore based firm to provide test credentials for IATA Travel Pass
Accredify, a Singapore-based firm that creates and issues verifiable documents, today announced that it has signed an agreement with the IATA to issue COVID-19 Test Credentials that will be accepted for IATA Travel Pass.
This collaboration will make Accredify one of the first lab and clinic aggregators in the Asia-Pacific region to participate in the IATA Travel Pass.
With the agreement, COVID-19 test credentials issued by Accredify’s network of healthcare providers in the Asia-Pacific region will be securely transmitted to IATA’s Travel Pass.
The IATA Travel Pass was developed to provide a secure and privacy-protecting solution for airlines and governments to accurately verify a passenger’s COVID-19 health status. As of July 2021, over 70 airlines are trialing or committed to trial the IATA Travel Pass.
“Verified testing is the immediate solution to give governments the confidence to re-open their borders to travellers,” says Nick Careen, IATA’s senior vice president for operations, safety and security.
“The IATA Travel Pass aims to make it as simple as possible for travellers to locate certified labs and securely receive the test results that governments require.
“Adding Accredify’s extensive lab network will help travellers more easily ensure that they meet their COVID-19 travel requirements.”
Accredify claims that it has been on the forefront of driving the adoption of verifiable COVID-19 health credentials to facilitate domestic and international movement.
The firm issued Singapore’s first verifiable COVID-19 test result in October 2020, and co-developed Singapore’s HealthCerts schema, a template for digital COVID-19 test results which has since been mandated by the Singapore government.